209 related articles for article (PubMed ID: 17937629)
1. Current trends in immunosuppression.
González Posada JM
Nefrologia; 2006; 26 Suppl 2():3-8. PubMed ID: 17937629
[No Abstract] [Full Text] [Related]
2. Sirolimus, the first mTOR inhibitor.
Sánchez-Plumed JA; González Molina M; Alonso A; Arias M
Nefrologia; 2006; 26 Suppl 2():21-32. PubMed ID: 17937632
[No Abstract] [Full Text] [Related]
3. [Immunosuppression in kidney transplantation].
Legendre C; Zuber J; Anglicheau D; Le Quintrec M; Martinez F; Mamzer-Bruneel MF; Thervet E
Ann Urol (Paris); 2007 Dec; 41(6):276-84. PubMed ID: 18457319
[TBL] [Abstract][Full Text] [Related]
4. Clinical evidence on the use of anti-mTOR drugs in renal transplantation.
Hernández D; Martínez D; Gutiérrez E; López V; Gutiérrez C; García P; Cobelo C; Cabello M; Burgos D; Sola E; González-Molina M
Nefrologia; 2011; 31(1):27-34. PubMed ID: 21270910
[TBL] [Abstract][Full Text] [Related]
5. Balancing efficacy and toxicity in kidney-transplant immunosuppression.
Leichtman AB
N Engl J Med; 2007 Dec; 357(25):2625-7. PubMed ID: 18094383
[No Abstract] [Full Text] [Related]
6. Everolimus: efficacy and safety in cardiac transplantation.
Schaffer SA; Ross HJ
Expert Opin Drug Saf; 2010 Sep; 9(5):843-54. PubMed ID: 20701555
[TBL] [Abstract][Full Text] [Related]
7. Sirolimus use in de "novo renal" transplantation.
Grinyo JM; Alonso A; Arias M; Campistol JM; González Molina M; González Posada JM; Morales JM; Oppenheimer F; Sánchez Fructuoso A; Sánchez-Plumed J; Ruiz JC
Nefrologia; 2006; 26 Suppl 2():33-51. PubMed ID: 17937633
[No Abstract] [Full Text] [Related]
8. [Immunosuppression for kidney transplant recipients: current strategies].
Alberú J; Urrea EM
Rev Invest Clin; 2005; 57(2):213-24. PubMed ID: 16524061
[TBL] [Abstract][Full Text] [Related]
9. [Immunosuppressors].
Sánchez-Fructuoso AI
Nefrologia; 2008; 28 Suppl 5():21-5. PubMed ID: 18847416
[TBL] [Abstract][Full Text] [Related]
10. Is complete avoidance of calcineurin inhibitors or steroids now possible? Importance of patient selection and choice of regimen.
Vincenti F
Transplant Proc; 2001 Jun; 33(4 Suppl):11S-18S. PubMed ID: 11406263
[No Abstract] [Full Text] [Related]
11. [Everolimus: immunosuppression with antilymphoproliferative therapy].
Pascual J
Nefrologia; 2004; 24(2):112-23. PubMed ID: 15219086
[No Abstract] [Full Text] [Related]
12. mTOR inhibitor versus mycophenolic acid as the primary immunosuppression regime combined with calcineurin inhibitor for kidney transplant recipients: a meta-analysis.
Xie X; Jiang Y; Lai X; Xiang S; Shou Z; Chen J
BMC Nephrol; 2015 Jul; 16():91. PubMed ID: 26126806
[TBL] [Abstract][Full Text] [Related]
13. [Everolimus and azoospermia, a causal relationship? About one case in a renal transplant patient].
Wetzstein M; Weestel PF; Choukroun G
Nephrol Ther; 2014 Feb; 10(1):44-5. PubMed ID: 24374233
[TBL] [Abstract][Full Text] [Related]
14. Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs.
Lindenfeld J; Miller GG; Shakar SF; Zolty R; Lowes BD; Wolfel EE; Mestroni L; Page RL; Kobashigawa J
Circulation; 2004 Dec; 110(25):3858-65. PubMed ID: 15611389
[No Abstract] [Full Text] [Related]
15. Everolimus: a guide to its use in liver transplantation.
Keating GM; Lyseng-Williamson KA
BioDrugs; 2013 Aug; 27(4):407-11. PubMed ID: 23696253
[TBL] [Abstract][Full Text] [Related]
16. mTOR Inhibition and Clinical Transplantation: Kidney.
Flechner SM
Transplantation; 2018 Feb; 102(2S Suppl 1):S17-S18. PubMed ID: 28230636
[No Abstract] [Full Text] [Related]
17. [Toward individualized immunosuppression].
Grinyó JM
Nefrologia; 2001; 21(3):232. PubMed ID: 11471302
[No Abstract] [Full Text] [Related]
18. Conversion to sirolimus.
Ruiz JC; Alonso A; Arias M; Campistol JM; González Molina M; González Posada JM; Grinyo JM; Morales JM; Oppenheimer F; Sánchez Fructuoso A; Sánchez-Plumed J
Nefrologia; 2006; 26 Suppl 2():52-63. PubMed ID: 17937634
[No Abstract] [Full Text] [Related]
19. Sirolimus to replace calcineurin inhibitors? Too early yet.
Cravedi P; Ruggenenti P; Remuzzi G
Lancet; 2009 Apr; 373(9671):1235-6. PubMed ID: 19362662
[No Abstract] [Full Text] [Related]
20. [Evidences in immunosuppression in the maintenance of renal transplantation].
Hernández D; González-Posada JM
Nefrologia; 2005; 25(4):369-80. PubMed ID: 16231502
[No Abstract] [Full Text] [Related]
[Next] [New Search]
